Analysis of CacyBP / SIP , ERK1 /2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma
Cancer Medicine · 2026
DOI: 10.1002/cam4.71649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Natalia Domian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cytophysiology, Medical University of Białystok, Białystok, Poland. Hauptthemen laut MEDLINE: p38 Mitogen-Activated Protein Kinases, Urinary Bladder Neoplasms, Mitogen-Activated Protein Kinase 3, Calcium-Binding Proteins. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Medyczny w Białymstoku.
Abstract (Originalsprache)
Background
Papillary urothelial carcinoma (transitional cell carcinoma) is one of the most common malignant tumors of the urinary tract. Urothelial carcinomas are classified into muscle‐invasive and non‐muscle‐invasive types. Among the latter, papillary urothelial carcinoma is further categorized into low‐grade and high‐grade forms. The aggressiveness of bladder cancer depends on the stage and grade of the disease. The CacyBP/SIP protein and MAP kinases play key roles in various cellular processes and signaling pathways that determine cell survival or death. This study aimed to assess the expression of CacyBP/SIP, ERK1/2, and p38 in low‐ and high‐grade papillary urothelial carcinoma using immunohistochemical and molecular analyses. Materials and Methods Tissue samples were obtained from 20 patients with high‐grade urothelial carcinoma and 20 patients with low‐grade urothelial carcinoma. Adjacent non‐cancerous tissues served as comparative controls. Immunohistochemistry and qRT‐PCR were used to evaluate the expression of CacyBP/SIP, ERK1/2, and p38.
Results
The strongest expression of the CacyBP/SIP gene was observed in tumor tissues with high malignant potential, predominantly in the nuclear compartment. Similarly, p38 kinase expression was elevated, whereas ERK1/2 expression was reduced in bladder tumor tissues compared to adjacent normal bladder tissues.
Conclusions
These findings suggest that CacyBP/SIP may play a critical role in urothelial carcinoma progression by modulating ERK1/2 and p38 kinase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Cytophysiology, Medical University of Białystok, Białystok, Poland.
- Department of Urology, Medical University of Białystok, Białystok, Poland.
ORCID-Profile: Irena Kasacka
Förderung
- Uniwersytet Medyczny w Białymstoku
Zitieren
APA
Domian, N., Młynarczyk, G., & Kasacka, I. (2026). Analysis of CacyBP / SIP , ERK1 /2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.71649
Vancouver
Domian N, Młynarczyk G, Kasacka I. Analysis of CacyBP / SIP , ERK1 /2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma. Cancer Medicine. 2026. doi:10.1002/cam4.71649
BibTeX
@article{Domian2026,
author = {Domian, Natalia and Młynarczyk, Grzegorz and Kasacka, Irena},
title = {Analysis of CacyBP / SIP , ERK1 /2, and p38 Expression in Low‐ and High‐Grade Papillary Urothelial Carcinoma},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71649}
}
EUVIMED